William Schmidt

802 total citations
6 papers, 622 citations indexed

About

William Schmidt is a scholar working on Oncology, Biotechnology and Surgery. According to data from OpenAlex, William Schmidt has authored 6 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Biotechnology and 1 paper in Surgery. Recurrent topics in William Schmidt's work include HER2/EGFR in Cancer Research (2 papers), Cancer Research and Treatments (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). William Schmidt is often cited by papers focused on HER2/EGFR in Cancer Research (2 papers), Cancer Research and Treatments (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). William Schmidt collaborates with scholars based in United States. William Schmidt's co-authors include John C. Deutsch, Henry Q. Xiong, Albert F. LoBuglio, Robert A. Wolff, Michael N. Needle, James L. Abbruzzese, Arthur Rosenberg, Brian A. Bartz, William T. Pennington and Martin Brunner and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Arthroscopy The Journal of Arthroscopic and Related Surgery.

In The Last Decade

William Schmidt

6 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William Schmidt United States 4 341 233 232 122 117 6 622
Caitlin A. McIntyre United States 13 366 1.1× 155 0.7× 117 0.5× 90 0.7× 80 0.7× 35 495
Takayoshi Kaida Japan 16 401 1.2× 273 1.2× 137 0.6× 143 1.2× 155 1.3× 44 761
Chihao Zhang China 19 175 0.5× 210 0.9× 145 0.6× 180 1.5× 142 1.2× 45 610
Brian E. Kadera United States 9 327 1.0× 183 0.8× 110 0.5× 94 0.8× 175 1.5× 23 550
Hongwei Xu China 13 203 0.6× 204 0.9× 120 0.5× 102 0.8× 102 0.9× 48 603
Emiko Mori Japan 10 281 0.8× 179 0.8× 62 0.3× 111 0.9× 119 1.0× 25 540
P. Ruszniewski France 14 376 1.1× 340 1.5× 473 2.0× 67 0.5× 100 0.9× 54 869
Reiichiro Kondo Japan 12 180 0.5× 203 0.9× 176 0.8× 70 0.6× 91 0.8× 42 562
Katsuji Hisakura Japan 14 114 0.3× 376 1.6× 231 1.0× 91 0.7× 68 0.6× 49 709
Keishi Nakamura Japan 14 227 0.7× 144 0.6× 66 0.3× 168 1.4× 85 0.7× 57 585

Countries citing papers authored by William Schmidt

Since Specialization
Citations

This map shows the geographic impact of William Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Schmidt more than expected).

Fields of papers citing papers by William Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Schmidt. The network helps show where William Schmidt may publish in the future.

Co-authorship network of co-authors of William Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of William Schmidt. A scholar is included among the top collaborators of William Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Schmidt. William Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
2.
Schneeberger, Achim, Suzanne Hendrix, Markus Mandler, et al.. (2015). RESULTS FROM A PHASE II STUDY TO ASSESS THE CLINICAL AND IMMUNOLOGICAL ACTIVITY OF AFFITOPE® AD02 IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE. The Journal of Prevention of Alzheimer s Disease. 2(2). 1–12. 32 indexed citations
3.
O’Reilly, Eileen M., Lon Smith, Johanna C. Bendell, et al.. (2014). Phase Ib of anticancer stem cell antibody OMP-59R5 (anti-Notch2/3) in combination with nab-paclitaxel and gemcitabine (Nab-P+Gem) in patients (pts) with untreated metastatic pancreatic cancer (mPC).. Journal of Clinical Oncology. 32(3_suppl). 220–220. 9 indexed citations
4.
Singavi, Arun K., William Schmidt, Daniel Eastwood, et al.. (2014). Safety of Outpatient Autologous Hematopoietic Cell Transplantation (AuHCT) for Multiple Myeloma and Lymphoma. Biology of Blood and Marrow Transplantation. 20(2). S114–S114. 2 indexed citations
6.
Xiong, Henry Q., Arthur Rosenberg, Albert F. LoBuglio, et al.. (2004). Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial. Journal of Clinical Oncology. 22(13). 2610–2616. 389 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026